BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4231141)

  • 1. [Behavior of the kallikrein inhibitor against enzymes, 3. Behavior of the kallikrein inhibitor from bovine lung against proteases].
    Kraut H; Bhargava N
    Hoppe Seylers Z Physiol Chem; 1967 Nov; 348(11):1498-9. PubMed ID: 4231141
    [No Abstract]   [Full Text] [Related]  

  • 2. [Behavior of the kallikrein inhibitor against enzymes, IV. Behavior of the kallikrein inhibitor from bovine organs against trypsin and chymotrypsin].
    Kraut H; Bhargava N
    Hoppe Seylers Z Physiol Chem; 1967 Nov; 348(11):1500-1. PubMed ID: 5300803
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies of kallikrein inhibitors in potatoes. II. Effect of potato kallikrein inhibitors on various kallikreins and other proteases.
    Hojima Y; Moriya H; Moriwaki C
    J Biochem; 1971 Jun; 69(6):1027-32. PubMed ID: 4253726
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the kallikrein-trypsin-inhibitor].
    Trautschold I; Werle E; Zickgraf-Rüdel G
    Arzneimittelforschung; 1966 Nov; 16(11):1507-15. PubMed ID: 4233517
    [No Abstract]   [Full Text] [Related]  

  • 5. [New polyvalent protease inhibitors for trypsin, chymotrypsin, plasmin and kallikreins from snails (Helix pomatia)].
    Tschesche H; Dietl T; Marx R; Fritz H
    Hoppe Seylers Z Physiol Chem; 1972 Mar; 353(3):483-6. PubMed ID: 4260409
    [No Abstract]   [Full Text] [Related]  

  • 6. [Polyvalent protease inhibitors in sea anemones (Actinaria) with an inhibition spectrum analogous to that of the trypsin-kallikrein inhibitor from bovine organs].
    Béres L; Kortmann H; Fritz H
    Hoppe Seylers Z Physiol Chem; 1972 Jan; 353(1):111-2. PubMed ID: 4401402
    [No Abstract]   [Full Text] [Related]  

  • 7. [Polyvalent isoinhibitors for trypsin, chymotrypsin, plasmin and kallikreins of sea anemones (Anemonia sulcata), isolation, inhibitory behavior and amino acid composition].
    Fritz H; Brey B; Béress L
    Hoppe Seylers Z Physiol Chem; 1972 Jan; 353(1):19-30. PubMed ID: 4401404
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of proteases in coagulation, kinin-forming and complement systems by alpha2-plasmin inhibitor.
    Moroi M; Aoki N
    J Biochem; 1977 Oct; 82(4):969-72. PubMed ID: 144728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New protease-inhibitors with broad specificity in the polychaet Sabellastarte indica (Savingny), I (author's transl)].
    Gauwerky C; Corman G; Uhlenbruck G
    Z Klin Chem Klin Biochem; 1975 Oct; 13(10):429-35. PubMed ID: 128215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Identification of lysine and arginine residues as inhibitory centers of protease inhibitors by means of maleic anhydride and butane-(2.3)-dione].
    Fritz H; Fink E; Gebhardt M; Hochstrasser K; Werle E
    Hoppe Seylers Z Physiol Chem; 1969 Aug; 350(8):933-44. PubMed ID: 4241154
    [No Abstract]   [Full Text] [Related]  

  • 11. Purification and characterization of the major cationic kallikrein inhibitor in bovine pituitary gland.
    Ikekita M; Jone CS; Kamo M; Tsugita A; Kizuki K; Moriya H
    Protein Seq Data Anal; 1992; 5(1):7-11. PubMed ID: 1283464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of inhibition of human plasma kallikrein by a site-specific modified inhibitor Arg15-aprotinin: evaluation using a microplate system and comparison with other proteases.
    Scott CF; Wenzel HR; Tschesche HR; Colman RW
    Blood; 1987 May; 69(5):1431-6. PubMed ID: 2436687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aprotinin: mechanism of action and therapeutical uses.
    Fussi F
    Boll Chim Farm; 1980 Nov; 119(11):631-46. PubMed ID: 6164378
    [No Abstract]   [Full Text] [Related]  

  • 14. A new broad spectrum inhibitor of esteroproteases, 4-(2-carboxyethyl) phenyl-trans-4-aminomethyl cyclohexane carboxylate hydrochloride (DV 1006).
    Maki M; Sasaki K
    Tohoku J Exp Med; 1972 Mar; 106(3):233-48. PubMed ID: 4261023
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effectiveness of commercial polyvalent proteinase inhibitors. Comparative analysis of their effect on kallikreins from different sources and trypsin].
    Iarovaia GA; Dotsenko VL; Agapova EI; Stepanian EP
    Vopr Med Khim; 1980; 26(6):832-7. PubMed ID: 6161484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of protease tissue inhibitor on the activity of pancreatic proteolytic enzymes in in-vitro experiments].
    Egorova EF; Chernoiarova OD; Ryzhkova GI
    Eksp Klin Farmakol; 1992; 55(3):39-41. PubMed ID: 1458161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of Trasylol on the effect of various proteases on erythrocytes].
    Uhlenbruck G; Wintzer G
    Klin Wochenschr; 1969 Jun; 47(12):673-5. PubMed ID: 5309810
    [No Abstract]   [Full Text] [Related]  

  • 18. Some properties of an antiplasmin substance from rabbit platelets.
    Wakabayashi K; Fujikawa K; Abe T
    Thromb Diath Haemorrh; 1970 Oct; 24(1):76-84. PubMed ID: 4249469
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the distribution of proteinase inhibitors of broad specificity in the organs of cuttle fish (Loligo vulgaris) (author's transl)].
    Tschesche H; von Rücker A
    Hoppe Seylers Z Physiol Chem; 1973; 354(10-11):1510-2. PubMed ID: 4279880
    [No Abstract]   [Full Text] [Related]  

  • 20. Purification of a new plasma inhibitor of kallikrein.
    Sumi H; Fujii S
    J Biochem; 1974 Mar; 75(3):541-51. PubMed ID: 4276127
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.